news

Biovista Inc. announces positive efficacy results in a pre-clinical trial of its BVA-601 drug for Epilepsy - 23/06/2009 more ...

Biovista Inc. Announces Positive Efficacy Results in a Pre-Clinical Trial of its BVA-101 Repositioned Drug for Multiple Sclerosis - 02/04/2009 more ...

Biovista delivers critical data for the CTSA Pharmaceutical Assets Portal - 12/02/2009 more ...
Copyright (c) 2008 Biovista Inc. All rights reserved. about | contact us | research | technology | legal | site map | index